| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |